ACRS and DCI Merge to Form New eCRO Services Provider
ACRS and DCI Merge to Form New eCRO Services Provider ??? BANNOCKBURN, Ill. and MARIETTA, Ga., May 2 /PRNewswire/ -- Advanced Clinical Research Services, LLC (ACRS) and Data Capture International, Inc. (DCI) announced their recent merger to offer eCRO services - enhanced biometrics services using technology enabled tools and platforms - to pharmaceutical and biotechnology companies that are performing clinical trials to meet regulatory submission requirements for the US Food and Drug Administration and other global agencies. ACRS has provided clinical data management services since 1994 and has built an exceptional reputation for quality and customer service. The company's clinical data management system (CDMS) is built on an Oracle Clinical(R) platform, and has been used in providing services for more than two-hundred clinical trials in nine therapeutic areas. ACRS's client base includes large and small pharmaceutical firms as well as biotechnology companies. DCI, founded in 2002, is an Application Service Provider that offers Electronic Data Capture (EDC) software solutions and services to pharmaceutical companies and Contract Research Organizations that perform early stage human clinical trials. With the SureLynx(TM) technology platform, DCI is becoming a recognized leader as a provider of technology enhanced clinical data management solutions.
BANNOCKBURN, Ill. and MARIETTA, Ga., May 2 /PRNewswire -- Advanced Clinical Research Services, LLC (ACRS) and Data Capture International, Inc. (DCI) announced their recent merger to offer eCRO services - enhanced biometrics services using technology enabled tools and platforms - to pharmaceutical and biotechnology companies that are performing clinical trials to meet regulatory submission requirements for the US Food and Drug Administration and other global agencies.
ACRS has provided clinical data management services since 1994 and has built an exceptional reputation for quality and customer service. The company's clinical data management system (CDMS) is built on an Oracle Clinical(R) platform, and has been used in providing services for more than two-hundred clinical trials in nine therapeutic areas. ACRS's client base includes large and small pharmaceutical firms as well as biotechnology companies.
DCI, founded in 2002, is an Application Service Provider that offers Electronic Data Capture (EDC) software solutions and services to pharmaceutical companies and Contract Research Organizations that perform early stage human clinical trials. With the SureLynx(TM) technology platform, DCI is becoming a recognized leader as a provider of technology enhanced clinical data management solutions.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
